Substrate reduction therapy for inborn errors of metabolism by Yue, WW, Mackinnon, S, Arruda Bezerra, G

Entropy-driven binding of opioid peptides induces a large domain motion in human dipeptidyl peptidase III by Arruda Bezerra, G, Dobrovetsky, E, Viertlmayr, R, Dong, A, Binter, A, Abramić, M, Macheroux, P, Dhe-Paganon, S, Gruber, K

Crystal structure and interaction studies of human DHTKD1 provide insight into a mitochondrial megacomplex in lysine catabolism by Arruda Bezerra, G, Foster, WR, Bailey, HJ, Hicks, KG, Sauer, SW, Dimitrov, B, McCorvie, TJ, Okun, JG, Rutter, J, Kölker, S, Yue, WW

Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release by Bailey, HJ, Arruda Bezerra, G, Marcero, JR, Padhi, S, Foster, WR, Rembeza, E, Roy, A, Bishop, DF, Desnick, RJ, Bulusu, G, Dailey, HA, Yue, WW

Fragment screening reveals starting points for rational design of galactokinase 1 inhibitors to treat classic galactosemia by Mackinnon, SR, Krojer, T, Foster, WR, Diaz-Saez, L, Tang, M, Huber, KVM, von Delft, F, Lai, K, Brennan, PE, Arruda Bezerra, G, Yue, WW